ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Psychiatry

Top Psychiatry Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHAT PHAM M.D.

Psychiatry

3,690

$410K

407
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$111
Average prescription price

Avg: $147

ATHI VENKATESH MD

Psychiatry

4,763

$652K

407
84 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 26%

$137
Average prescription price

Avg: $147

KRISHNAIAH RAYASAM MD

Psychiatry

7,391

$1.01M

406
65 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$137
Average prescription price

Avg: $147

NANJAPPA SREENIVAS M.D.

Psychiatry

4,809

$615K

404
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $147

JEAN JOSEPH-VANDERPOOL M.D.

Psychiatry

6,213

$1.06M

403
53 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$170
Average prescription price

Avg: $147

DANIELA BADEA-MIC M.D.

Psychiatry

3,134

$484K

400
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$154
Average prescription price

Avg: $147

MOHSIN QAYYUM M.D.

Psychiatry

2,866

$265K

399
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 26%

$93
Average prescription price

Avg: $147

AJINDER DHATT M.D.

Psychiatry

5,248

$671K

399
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $147

UMAMAHESWARA MARUVADA MD

Psychiatry

6,266

$1.12M

398
73 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$179
Average prescription price

Avg: $147

CHRISTOPHER BOEHME M.D.

Psychiatry

3,138

$392K

393
46 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$125
Average prescription price

Avg: $147

RUSSELL BACH M.D.

Psychiatry

5,812

$1.11M

392
21 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$192
Average prescription price

Avg: $147

SHEALYN CYR MD

Psychiatry

2,393

$238K

392
254 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $147

CINDY MARSHALL M.D.

Psychiatry

3,184

$595K

391
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 26%

$187
Average prescription price

Avg: $147

HERBERT DAVIS MD

Psychiatry

5,460

$884K

386
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$162
Average prescription price

Avg: $147

KOCHUPARAMPIL VARGHESE MD

Psychiatry

6,935

$990K

379
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$143
Average prescription price

Avg: $147

GHULAM KHAN M.D.

Psychiatry

3,399

$560K

378
15 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$165
Average prescription price

Avg: $147

MOHAMED AHMED MD

Psychiatry

2,745

$400K

378
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$146
Average prescription price

Avg: $147

GABRIELLA PASZTOR M.D.

Psychiatry

3,201

$227K

375
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $147

BENNY BARNHART M.D.

Psychiatry

4,019

$456K

373
227 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$113
Average prescription price

Avg: $147

DAVID KORMAN M.D.

Psychiatry

6,226

$893K

373
46 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$143
Average prescription price

Avg: $147

JOSEFINA DIAZ-VOGT M.D.

Psychiatry

4,453

$952K

372
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 26%

$214
Average prescription price

Avg: $147

GURDIP BUTTAR M.D.

Psychiatry

6,701

$893K

370
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $147

RAMESH PARIKH MD

Psychiatry

5,155

$844K

366
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$164
Average prescription price

Avg: $147

HELENE ALPHONSO DO

Psychiatry

2,572

$529K

363
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$206
Average prescription price

Avg: $147

ROY MATHEW MD

Psychiatry

4,478

$952K

358
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$213
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank